C

CVF

North America, California, United States, Davis

Description

an affiliate of Henry Crown and Company

Investor Profile

CVF has made 7 investments, with 0 in the past 12 months and 43% as lead.

Stage Focus

  • Series C (43%)
  • Private Equity (29%)
  • Series E (14%)
  • Series D (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Nanotechnology
  • Oncology
  • Therapeutics
  • Manufacturing
  • Retail
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CVF frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 2
Meritech Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Lux Capital
North America, New York, United States, New York
Co-Investments: 3
Fjord Ventures
North America, California, United States, Laguna Hills
Co-Investments: 2
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 2
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by CVF?

Sonendo

Laguna Hills, California, United States

Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy.

BiotechnologyHealth CareMedical
Private EquitySep 18, 2017
Amount Raised: $50,000,000
Sonendo

Laguna Hills, California, United States

Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy.

BiotechnologyHealth CareMedical
Series EDec 13, 2016
Amount Raised: $35,000,000
Cerulean Pharma

Cambridge, Massachusetts, United States

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

BiotechnologyHealth CareNanotechnologyOncologyTherapeutics
Private EquityDec 14, 2012
Amount Raised: $13,000,000
Genocea Biosciences

Cambridge, Massachusetts, United States

Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.

BiotechnologyHealth CareMedical
Series COct 10, 2012
Amount Raised: $30,000,000
Cerapedics

Westminster, Colorado, United States

CeraPedics is a medical device company that focuses on developing and commercializing novel osteobiologic products.

BiotechnologyHealth CareMedical Device
Series CJul 23, 2012
Amount Raised: $19,000,000
Cerulean Pharma

Cambridge, Massachusetts, United States

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

BiotechnologyHealth CareNanotechnologyOncologyTherapeutics
Series DDec 15, 2011
Amount Raised: $15,000,000
Amnis Corporation

Seattle, Washington, United States

Amnis is a manufacturer and supplier of flow cytometry products and services.

BiotechnologyManufacturingRetail
Series CAug 29, 2005
Amount Raised: $11,250,000